Breaking News Instant updates and real-time market news.

RE

Everest Re

$222.48

10.54 (4.97%)

, XL

XL Group

$38.61

2.13 (5.84%)

06:49
09/11/17
09/11
06:49
09/11/17
06:49

Irma and Harvey insured losses expected to top $100B, says Barclays

Barclays analyst Jay Gelb notes initial indications are Hurricane Irma's impact on Florida could result in insured losses of up to $60B. Irma will likely be the largest storm to ever impact the U.S., although not as bad as if Miami suffered a direct hit, Gelb tells investors in a research note on the insurance space titled "Devastating Irma Impact on Insurers, But It Could Have Been Worse." All in, Irma and Harvey insured losses are expected to exceed $100B, Gelb points out. He believes the re/insurance stocks could suffer from near-term uncertainty regarding the extent of losses. Of the names he covers, the analyst expects Everest Re (RE), XL Group (XL), RenaissanceRe (RNR), Validus (VR) and Aspen Insurance (AHL) "to take the brunt of Irma losses." Book value declines of more than 20% could require equity capital raises, Gelb contends. He says Chubb (CB), Travelers (TRV) and Hartford Financial (HIG) have relatively less exposure while AIG (AIG) could have greater losses among the primary insurers.

RE

Everest Re

$222.48

10.54 (4.97%)

XL

XL Group

$38.61

2.13 (5.84%)

RNR

RenaissanceRe

$129.00

5.12 (4.13%)

VR

Validus

$44.02

1.84 (4.36%)

AHL

Aspen Insurance

$38.15

1.7 (4.66%)

CB

Chubb

$140.85

5.97 (4.43%)

TRV

Travelers

$119.76

4.58 (3.98%)

HIG

Hartford Financial

$53.17

1.53 (2.96%)

AIG

AIG

$59.78

1.51 (2.59%)

RE Everest Re
$222.48

10.54 (4.97%)

08/28/17
JPMS
08/28/17
NO CHANGE
JPMS
JPMorgan sees up to $20B of insured losses from Harvey
Harvey could result in $10B-$20B of industry insured losses making it one of the top 10 most costly hurricanes to hit the U.S., JPMorgan analyst Sarah DeWitt tells investors in a research note. The analyst lists Validus (VR), RenaissanceRe (RNR), Everest Re (RE), XL Group (XL), Arch Capital (ACGL), Travelers (TRV), Chubb (CB), Allstate (ALL) and Progressive (PGR) as the property casualty insurers with the most exposure to Texas hurricanes.
11/15/16
GSCO
11/15/16
UPGRADE
Target $195
GSCO
Neutral
Everest Re upgraded to Neutral from Sell at Goldman
Goldman analyst Michael Nannizzi upgraded Everest Re to Neutral and raised its price target to $195 from $166 saying he does not see any near-term catalysts that would cause shares to meaningfully underperform given the hurricane season has passed.
07/17/17
KBWI
07/17/17
DOWNGRADE
Target $245
KBWI
Underperform
Everest Re downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Meyer Shields downgraded Everest Re to Underperform and lowered his price target for the shares to $245 from $251. The analyst has valuation concerns given the company's exposure to current property reinsurance market conditions.
01/17/17
MACQ
01/17/17
DOWNGRADE
MACQ
Underperform
Everest Re downgraded to Underperform from Neutral at Macquarie
Macquarie analyst Amit Kumar downgraded Everest Re to Underperform with a $186 price target. The analyst expects reinsurers to trade at lower levels in 2017/2018 as the focus surrounds the commercial names in 2017 due to taxation headlines.
XL XL Group
$38.61

2.13 (5.84%)

07/28/17
JPMS
07/28/17
UPGRADE
Target $52
JPMS
Overweight
XL Group upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Sarah DeWitt upgraded XL Group to Overweight and raised his price target for the shares to $52 from $45. The company is the best value play in the group and the risk/reward appears "increasingly attractive" after the Q2 earnings selloff, DeWitt tells investors in a research note.
07/28/17
JPMS
07/28/17
DOWNGRADE
Target $145
JPMS
Neutral
RenaissanceRe downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Sarah DeWitt downgraded RenaissanceRe (RNR) to Neutral and lowered his price target for the shares to $145 from $165. The company could be challenged to improve return-on-equity and looks fairly valued, DeWitt tells investors in a research note. She coupled the downgrade with an upgrade of XL Group (XL) to Overweight.
03/13/17
SDLR
03/13/17
DOWNGRADE
Target $41
SDLR
Hold
XL Group downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Paul Newsome downgraded XL Group to Hold and lowered his price target for the shares to $41 from $46. The analyst sees a competitive market in most of XL's businesses and feels the company will be challenged to improve profit margins in a falling rate environment.
RNR RenaissanceRe
$129.00

5.12 (4.13%)

11/22/16
SBSH
11/22/16
INITIATION
Target $143
SBSH
Neutral
RenaissanceRe initiated with a Neutral at Citi
Citi analyst James Naklicki started RenaissanceRe with a Neutral rating and $143 price target. The analyst expects reinsurance pricing will continue to decline, putting pressure on total returns for reinsurance stocks.
11/21/16
DBAB
11/21/16
DOWNGRADE
DBAB
Hold
RenaissanceRe downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Joshua Shanker downgraded RenaissanceRe to Hold saying the shares are no longer attractive following the recent rally. The stock is trading in excess of 1.2 times year-ahead book value, Shanker tells investors in a research note.
VR Validus
$44.02

1.84 (4.36%)

09/23/16
UBSW
09/23/16
DOWNGRADE
Target $50
UBSW
Neutral
Validus downgraded to Neutral from Buy at UBS
UBS analyst Brian Meredith downgraded Validus to Neutral citing valuation. The analyst believes the stock's "re-rating story is largely complete" and he keeps a $50 price target for the shares.
02/06/17
DBAB
02/06/17
DOWNGRADE
Target $56
DBAB
Hold
Validus downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Joshua Shanker downgraded Validus to Hold citing valuation with the shares up nearly 20% over the past six months. The analyst raised his price target for the shares to $56 from $55.
AHL Aspen Insurance
$38.15

1.7 (4.66%)

01/09/17
UBSW
01/09/17
DOWNGRADE
Target $55
UBSW
Neutral
Aspen Insurance downgraded to Neutral from Buy at UBS
UBS analyst Brian Meredith downgraded Aspen Insurance to Neutral saying the shares look fairly valued at current levels. He raised his price target for the shares to $55 from $52.
CB Chubb
$140.85

5.97 (4.43%)

08/10/17
WELS
08/10/17
NO CHANGE
Target $164
WELS
Outperform
Chubb removed from Priority Stock List at Wells Fargo
Wells Fargo analyst Elyse Greenspan removed Chubb from her firm's Priority Stock List but keeps an Outperform rating on the shares with a $164 price target. The list now only includes Well's top pick in the non life insurance sector, the analyst adds.
09/01/17
MSCO
09/01/17
NO CHANGE
MSCO
Harvey loss uncertainty to remain overhang on P&C stocks, says Morgan Stanley
Morgan Stanley analyst Kai Pan currently estimates $15B-$40B in total insured losses from Harvey, including $5B-$15B in National Flood Insurance Program, or NFIP, claims. P&C stocks the firm covers have declined 2.7% on average since August 23, noted Pan, who thinks the uncertainty of losses will remain a near-term overhang on the group. If the ultimate losses are contained within quarterly earnings, the stocks could rebound, added Pan. Stocks in the P&C insurance space include Allstate (ALL), Travelers (TRV), Progressive (PGR), Chubb (CB), AIG (AIG).
04/26/17
RBCM
04/26/17
NO CHANGE
Target $153
RBCM
Outperform
Chubb price target raised to $153 from $140 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Chubb to $153 from $140 and reiterates an Outperform rating on the insurer, which he continues to view as his favorite large-cap P&C insurer.
TRV Travelers
$119.76

4.58 (3.98%)

06/19/17
06/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Costco (COST) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying positive pipeline catalysts have played out while competition is intensifying with Amazon.com (AMZN) and Wal-Mart (WMT) accelerating in-store and online efforts. The analyst lowered his price target for the shares to $172 from $187. 2. Kroger (KR) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Sinisi saying there is increased structural margin risk within the Food Retail sector following Amazon's (AMZN) acquisition of Whole Foods (WFM) and said stocks are now appropriately pricing in flat medium-term growth. 3. Wayfair (W) downgraded to Hold from Buy at Maxim with analyst Tom Forte saying he views the current share price as fully reflecting its revenue growth opportunity over the next three years and his expectation that the company can meet the top-end of its long-term adjusted EBITDA margin target of 8%-10%. 4. Travelers (TRV) downgraded to Neutral from Buy at BofA/Merrill with analyst Jay Cohen citing valuation. 5. TripAdvisor (TRIP) downgraded to Underperform from Neutral at Credit Suisse with analyst Paul Bieber citing raised expectations for TV ad spending in 2018 paired with uncertainty regarding the return on TV advertising investment given the crowded ad market for online travel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
ARGS
07/28/17
NO CHANGE
ARGS
Travelers weakness creates attractive entry point, says Argus
After Travelers reported lower than expected EPS, Argus analyst Jacob Kilstein notes that the company's Q2 revenue beat expectations. He expects the company's margins and ROIC to improve going forward and recommends buying the stock on weakness.
HIG Hartford Financial
$53.17

1.53 (2.96%)

06/19/17
DBAB
06/19/17
NO CHANGE
Target $60
DBAB
Buy
Hartford bear case has 'weak premises,' says Deutsche Bank
In a research note titled "Challenging the Bear Case," Deutsche Bank analyst Joshua Shanker argues that the bear case for shares of Hartford Financial has "weak premises." The cases, including a potential material acquisition, the sale of Talcott leading to a material writedown of book value and the company's deferred tax assets having no value, are "insufficient" to hold investors back from buying the shares, Shanker tells investors in a research note. The analyst sees "material" upside potential and keeps a Buy rating on Hartford with a $60 price target.
01/06/17
FBCO
01/06/17
DOWNGRADE
Target $53
FBCO
Neutral
Hartford Financial downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse downgraded Hartford Financial to Neutral from Outperform and increased its price target to $53 from $51. Analyst Ryan Tunis said shares have rerated since the election, partially on optimism around a potential sale of the run-off life unit, Talcott. Tunis thinks potential tax refrom makes Hartford less likely to sell Talcott as getting rid of AMT would accelerate Hartford's ability to realize cash value of the nearly $2B of DTA from NOLs that reside in Talcott. Further, the analyst believes there are two or three quarters of net positive reserve activity are needed for the stock to discount the idea of improved underwriting, which is unlikely in 2017 following Hartford's announcement that there is further adverse development in auto coming in the fourth quarter.
06/06/17
06/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hartford Financial (HIG) initiated with a Buy at Deutsche Bank. 2. FedEx (FDX) and UPS (UPS) were initiated with a Neutral at Seaport Global. 3. Gardner Denver (GDI) was initiated with an Outperform at William Blair and Baird, an Overweight at Piper Jaffray, a Buy at Stifel, UBS, and Goldman Sachs, as well as a Neutral at Credit Suisse. 4. Solaris Oilfield (SOI) was initiated with an Outperform at Wells Fargo, Oppenheimer, Evercore ISI, and Credit Suisse, an Overweight at Piper Jaffray, as well as a Buy at Goldman Sachs and Wunderlich. 5. LeMaitre (LMAT) initiated with a Hold at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/06/17
DBAB
06/06/17
INITIATION
Target $60
DBAB
Buy
Hartford Financial initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Joshua Shanker started Hartford Financial with a Buy rating and $60 price target. The sum of the parts at the company are worth "materially more than the stock price currently indicates," Shanker tells investors in a research note. The analyst, however, notes that he's not arguing for a break-up.
AIG AIG
$59.78

1.51 (2.59%)

08/09/17
ATLE
08/09/17
DOWNGRADE
ATLE
Neutral
AIG downgraded to Neutral from Overweight at Atlantic Equities
08/09/17
08/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) downgraded on more cautious U.S. comp sales outlook at BMO Capital with analyst Andrew Strelzik saying he's "more cautious" on the outlook for the company's U.S. comparable sales, partly due to increased cannibalization of stores, increased competition, "throughput headwinds," and the possibility that "contributions from beverage innovation and food growth may have peaked." 2. Albemarle (ALB) downgraded to Hold from Buy at SunTrust with analyst James Sheehan citing recent share strength. 3. Dean Foods (DF) downgraded to Market Perform from Outperform at Wells Fargo with analyst John Baumgartnerm citing the second quarter miss and "big" guidance reduction. 4. Air Lease (AL) downgraded to Neutral from Buy at BofA/Merrill with analyst Kristine Liwag citing valuation. 5. AIG (AIG) downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/17
DBAB
07/05/17
NO CHANGE
Target $57
DBAB
Sell
AIG Q2 results could be negative catalyst, says Deutsche Bank
Deutsche Bank analyst Joshua Shanker recommends investors consider that AIG's earnings results could be a negative catalyst. The analyst advises investor caution saying the company faces difficult year-ago comparables. He also believes the new CEO "will have no reason to paint the numbers as any better than they are." Shanker has a Sell rating on AIG with a $57 price target.

TODAY'S FREE FLY STORIES

ABT

Abbott

$84.25

-0.96 (-1.13%)

, ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

13:22
09/14/19
09/14
13:22
09/14/19
13:22
Conference/Events
William Blair diagnostic products/med tech analyst to hold a group luncheon »

Diagnostic Products &…

ABT

Abbott

$84.25

-0.96 (-1.13%)

ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

BDX

Becton Dickinson

$260.68

-1.41 (-0.54%)

COO

Cooper Companies

$301.95

-3 (-0.98%)

EXAS

Exact Sciences

$106.72

-1.99 (-1.83%)

GH

Guardant Health

$77.54

0.49 (0.64%)

NEO

NeoGenomics

$21.34

-1.22 (-5.41%)

LMNX

Luminex

$22.62

0.1 (0.44%)

HAE

Haemonetics

$125.55

-0.31 (-0.25%)

STAA

STAAR Surgical

$29.21

0.415 (1.44%)

QGEN

Qiagen

$33.97

-0.105 (-0.31%)

NVTA

Invitae

$21.70

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 13

    Nov

  • 05

    Dec

CRTO

Criteo

, TWTR

Twitter

13:19
09/14/19
09/14
13:19
09/14/19
13:19
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Technology & Internet…

CRTO

Criteo

TWTR

Twitter

SNAP

Snap

GOOGL

Alphabet Class A

FB

Facebook

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

T

AT&T

$37.90

-0.46 (-1.20%)

09:06
09/14/19
09/14
09:06
09/14/19
09:06
Periodicals
AT&T stock already benefiting from activist involvement, Barron's says »

AT&T 's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

DIS

Disney

$138.00

0.44 (0.32%)

, NFLX

Netflix

$294.00

5.08 (1.76%)

09:04
09/14/19
09/14
09:04
09/14/19
09:04
Periodicals
Consumers might not be as in love with Apple TV+ as Wall Street, Barron's says »

Following Apple's…

DIS

Disney

$138.00

0.44 (0.32%)

NFLX

Netflix

$294.00

5.08 (1.76%)

AAPL

Apple

$218.71

-4.4 (-1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Oct

UAL

United Airlines

$91.37

1.99 (2.23%)

08:58
09/14/19
09/14
08:58
09/14/19
08:58
Periodicals
United Airlines could get boost after short squeeze, Barron's says »

United Airlines stock has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

BAC

Bank of America

$30.12

0.44 (1.48%)

08:55
09/14/19
09/14
08:55
09/14/19
08:55
Periodicals
Bank of America stock worth betting on, Barron's says »

Amid talk of a coming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TPR

Tapestry

$25.16

-0.43 (-1.68%)

08:49
09/14/19
09/14
08:49
09/14/19
08:49
Periodicals
Coach parent's turnaround could be coming, Barron's says »

Even in a rough year for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$379.63

4.21 (1.12%)

08:45
09/14/19
09/14
08:45
09/14/19
08:45
Periodicals
U-Haul parent stock 'a better-kept secret,' Barron's says »

Amerco (UHAL), owner of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$228.59

-1.38 (-0.60%)

, CNI

Canadian National

$92.13

-0.31 (-0.34%)

08:41
09/14/19
09/14
08:41
09/14/19
08:41
Periodicals
Railroad stocks struggling as challenges increase, Barron's says »

North American railroads…

CP

Canadian Pacific

$228.59

-1.38 (-0.60%)

CNI

Canadian National

$92.13

-0.31 (-0.34%)

UNP

Union Pacific

$171.49

3.81 (2.27%)

CSX

CSX

$72.50

0.96 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

MO

Altria Group

$42.01

-0.77 (-1.80%)

, BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

08:06
09/14/19
09/14
08:06
09/14/19
08:06
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

MO

Altria Group

$42.01

-0.77 (-1.80%)

BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$73.01

-1.89 (-2.52%)

REGI

Renewable Energy

$15.90

0.57 (3.72%)

PSX

Phillips 66

$102.77

0.66 (0.65%)

MPC

Marathon Petroleum

$53.29

0.1 (0.19%)

VLO

Valero

$85.53

1.84 (2.20%)

EVA

Enviva

$31.21

0.06 (0.19%)

AMTX

Aemetis

$1.00

0.14 (16.28%)

PEIX

Pacific Ethanol

$0.78

0.0322 (4.29%)

GPP

Green Plains Partners

$13.18

0.17 (1.31%)

DK

Delek US

$35.91

-0.6 (-1.64%)

HFC

HollyFrontier

$51.41

0.71 (1.40%)

TSO

Tesoro

$0.00

(0.00%)

WNR

Western Refining

$0.00

(0.00%)

T

AT&T

$37.90

-0.46 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 23

    Oct

  • 24

    Oct

  • 31

    Oct

  • 12

    Nov

GLD

SPDR Gold Shares

$140.19

-1.14 (-0.81%)

17:58
09/13/19
09/13
17:58
09/13/19
17:58
Hot Stocks
SPDR Gold Shares holdings fall to 874.51MT from 880.37MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$10.22

0.595 (6.18%)

, AIMT

Aimmune

$24.66

(0.00%)

17:57
09/13/19
09/13
17:57
09/13/19
17:57
Hot Stocks
Breaking Hot Stocks news story on DBV Technologies, Aimmune »

DBV Technologies falls 2%…

DBVT

DBV Technologies

$10.22

0.595 (6.18%)

AIMT

Aimmune

$24.66

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

AIMT

Aimmune

$24.66

(0.00%)

17:55
09/13/19
09/13
17:55
09/13/19
17:55
Hot Stocks
FDA committee votes to support use of Aimmune's Palforzia for peanut allergy »

Aimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

ZAYO

Zayo Group

$33.82

-0.05 (-0.15%)

17:39
09/13/19
09/13
17:39
09/13/19
17:39
Hot Stocks
Zayo Group CEO sells 1M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

T

AT&T

$37.90

-0.46 (-1.20%)

, MO

Altria Group

$42.01

-0.77 (-1.80%)

17:38
09/13/19
09/13
17:38
09/13/19
17:38
Periodicals
CNN to longer run Juul ads, Daily Beast reports »

AT&T's (T) CNN…

T

AT&T

$37.90

-0.46 (-1.20%)

MO

Altria Group

$42.01

-0.77 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BAS

Basic Energy

$1.87

-0.08 (-4.10%)

17:34
09/13/19
09/13
17:34
09/13/19
17:34
Hot Stocks
Basic Energy CEO T.M. Patterson to leave company »

Basic Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

XBIO

Xenetic

$1.61

-0.04 (-2.42%)

17:28
09/13/19
09/13
17:28
09/13/19
17:28
Syndicate
Breaking Syndicate news story on Xenetic »

Xenetic files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$218.71

-4.4 (-1.97%)

, DIS

Disney

$138.00

0.44 (0.32%)

17:22
09/13/19
09/13
17:22
09/13/19
17:22
Hot Stocks
Disney CEO Bob Iger resigns from Apple board of directors »

In a regulatory filing,…

AAPL

Apple

$218.71

-4.4 (-1.97%)

DIS

Disney

$138.00

0.44 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PHG

Philips

$47.79

0.19 (0.40%)

17:21
09/13/19
09/13
17:21
09/13/19
17:21
Hot Stocks
Philips awarded maximum $400M Defense Logistics Agency contract »

Philips has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBSE

NeuBase Therapeutics

$5.70

-0.04 (-0.70%)

17:20
09/13/19
09/13
17:20
09/13/19
17:20
Syndicate
Breaking Syndicate news story on NeuBase Therapeutics »

NeuBase Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

KDMN

Kadmon

$2.80

-0.015 (-0.53%)

17:18
09/13/19
09/13
17:18
09/13/19
17:18
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.80

-0.015 (-0.53%)

17:18
09/13/19
09/13
17:18
09/13/19
17:18
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$198.82

1.22 (0.62%)

17:17
09/13/19
09/13
17:17
09/13/19
17:17
Hot Stocks
Raytheon awarded $427.3M Army procurement contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

INPX

Inpixon

$0.14

-0.0001 (-0.07%)

17:16
09/13/19
09/13
17:16
09/13/19
17:16
Syndicate
Breaking Syndicate news story on Inpixon »

Inpixon files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$6.59

0.14 (2.17%)

17:14
09/13/19
09/13
17:14
09/13/19
17:14
Syndicate
Aurinia Pharmaceuticals files to sell $40M of common shares at-the-market »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.